Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 2 - Number 3





A Facile Synthesis of C2-Substituted Pyrrolo[2,3-f]quinolines with Cytotoxic Activity

, 2(3): 189 - 192

Andrew Tsotinis, Margarita Vlachou, Spyridon Zouroudis, Andras Jeney, Ferenc Timar, David E. Thurston and Christos Roussakis


DOI: 10.2174/1570180053765075




Preliminary In vitro Results Indicating Tartronic Acids as Aspartic Acid Mimetics in Vitronectin Receptor Antagonists: Evidence for Increased Hydroxyapatite Affinity

, 2(3): 201 - 204

Diane B. Hauze, Kenneth L. Kees, Charles W. Mann, Horace Fletcher III, Richard Murrills, Jeanne Matteo, Frederick Bex, Bheem Bhat and Valerie Coleburn


DOI: 10.2174/1570180053765110



Pyrazinobenzodiazepines as Potent Nonpeptide Vasopressin Receptor Antagonists

, 2(3): 219 - 223

Jay M. Matthews, Dennis J. Hlasta, Patricia Andrade-Gordon, Keith T. Demarest, Eric Ericson, Joseph W. Gunnet, William Hageman, Richard Look, John B. Moore and Bruce E. Maryanoff


DOI: 10.2174/1570180053765183









Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog